BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2003
View Archived Issues
Four series of antiangiogenic peptides described by Abbott scientists
Read More
Merck claims novel tyrosine kinase inhibitors for use in cancer and other disorders
Read More
New PTP inhibitors prepared and tested at Applied Research Systems
Read More
Neurotrophic and neuroprotective agents identified by Toyama researchers
Read More
New HCV NS5B polymerase inhibitors in GSK development pipeline
Read More
Inhibitors of IKK2 and potential uses described in recent patent
Read More
New adenosine antagonists with utility in constipation, IBS, etc., covered by Eisai patent
Read More
Selenium reduces the risk of progression toward cancer in patients with Barrett's esophagus
Read More
Initial phase III results for canker sore treatment OraDisc A
Read More
Generex schedules Canadian phase IIb trials of Oralin
Read More
Cellegy appoints Neopharm to distribute Tostrex in Israel
Read More
Femara increases survival in advanced breast cancer
Read More
Fuzeon approved in E.U.
Read More
NM-702 enters late phase II trial for chronic arterial occlusion
Read More
DB-289 enters phase IIb PCP trial
Read More
Results for Thalomid and IMiDs in all stages of multiple myeloma
Read More
Arimidex evaluated in women at high risk for breast cancer, very early breast cancer
Read More
IND filed for Corus-1020, first patient enrolled in cystic fibrosis study
Read More
Orphan drug status awarded to KSB-303 for pancreatic cancer
Read More
Medarex reports preclinical results for anthrax antibody
Read More
Lilly terminates licensing agreement with Ono
Read More
PT-100 shows promise in chemotherapy-induced neutropenia
Read More
IND cleared for VaxGen's anthrax vaccine
Read More
Protherics intends to acquire Enact
Read More
Preliminary evaluation of novel 5-HT2B antagonist indicates potential in IBS
Read More
Prous Science announces the publication of a comprehensive review on SARS
Read More
Selective eradication of H. pylori with BYK-170424
Read More
Inotek advances orally active PARP inhibitor through clinical trials
Read More